High Blood Glucose Concentration Is a Risk Factor for Mortality in Middle-Aged Nondiabetic Men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study
@article{Balkau1998HighBG, title={High Blood Glucose Concentration Is a Risk Factor for Mortality in Middle-Aged Nondiabetic Men: 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study}, author={Beverley Balkau and Martin J. Shipley and R. John Jarrett and Kalevi Py{\"o}r{\"a}l{\"a} and Marja Py{\"o}r{\"a}l{\"a} and Anne Forhan and Eveline Eschwège}, journal={Diabetes Care}, year={1998}, volume={21}, pages={360 - 367} }
OBJECTIVE To assess the association between high but nondiabetic blood glucose levels and the risk of death from all causes, coronary heart disease (CHD), cardiovascular disease, and neoplasms. RESEARCH DESIGN AND METHODS We studied the 20-year mortality of non-diabetic, working men, age 44–55 years, in three European cohorts known as the Whitehall Study (n = 10,025), the Paris Prospective Study (n = 6,629), and the Helsinki Policeman Study (n = 631). These men were identified by their 2-h…
Figures and Tables from this paper
656 Citations
Fasting plasma glucose in non-diabetic elderly women predicts increased all-causes mortality and coronary heart disease risk.
- MedicineAustralian and New Zealand journal of medicine
- 2000
Fasting plasma glucose levels in the upper normal range in non-diabetic elderly subjects appear to be associated with increased all-causes mortality and CHD, especially in women.
Two hour plasma glucose is not unequivocally predictive for early death in men with impaired fasting glucose: more results from the Paris Prospective Study
- Medicine, ChemistryDiabetologia
- 2002
2hPG is unequivocally prognostic for all-cause mortality only in men with normal FPG, and Screening men with an IFG by using a 75 g OGTT is of limited benefit.
Fasting plasma glucose and subsequent macrovascular disease after 10 years follow-up: a collaborative study on two populations.
- MedicineQJM : monthly journal of the Association of Physicians
- 1999
These data, based on the excess risk of macrovascular disease experienced by a British cohort of non-diabetic men, accord with the proposals to base the diagnosis of diabetes on a cut point of 7.0 rather than 7.8 mmol/l.
Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study.
- MedicineDiabetes care
- 2006
A threshold model with linear slope best described the dose-response relationship between postload blood glucose and CHD mortality risk.
Impaired fasting glucose concentrations in nondiabetic patients with ischemic heart disease: a marker for a worse prognosis.
- MedicineAmerican heart journal
- 2001
The main finding of this study is the substantially increased mortality rate among nondiabetic coronary patients with IFG, who had fasting glucose levels markedly lower than hitherto acknowledged as defining overt diabetes.
Glycated Hemoglobin and Risk of Stroke in People Without Known Diabetes in the European Prospective Investigation Into Cancer (EPIC)–Norfolk Prospective Population Study: A Threshold Relationship?
- MedicineStroke
- 2007
The association between blood glucose level and stroke risk appears to be more consistent with a threshold relationship, which may give insights into the differing pathogenesis of different vascular diseases.
Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.
- MedicineArchives of internal medicine
- 2001
The 2h-BG is a better predictor of deaths from all causes and cardiovascular disease than is FBG.
Impaired glucose tolerance as a risk factor for stroke in a cohort of non-institutionalised people aged 70 years.
- MedicineAge and ageing
- 2006
In the Turku Elderly Study, stroke tended to happen more often in the IGT group than in the normal group, but the difference was not statistically significant.
Blood glucose: a strong risk factor for mortality in nondiabetic patients with cardiovascular disease.
- MedicineAmerican heart journal
- 2005
Framingham Risk Score Assessment in Subjects with Pre-diabetes and Diabetes: A Cross-Sectional Study in Korea
- MedicineJournal of obesity & metabolic syndrome
- 2021
Overall, Korean subjects with pre-diabetes and diabetes have an increased cardiovascular risk, which is significantly higher in those subjects with diabetes than with before, which can be used to develop measures to prevent and manage cardiovascular complications in Koreans with impaired glucose metabolism.
References
SHOWING 1-10 OF 24 REFERENCES
CORONARY-HEART-DISEASE RISK AND IMPAIRED GLUCOSE TOLERANCE The Whitehall Study
- MedicineThe Lancet
- 1980
Sex differences in fasting glycemia as a risk factor for ischemic heart disease death.
- MedicineAmerican journal of epidemiology
- 1991
Sex differences in the effect of fasting glycemia on ischemic heart disease mortality among nondiabetics exist and are unexplained, and elucidation may hold a key to the sex difference in heart disease.
Is hyperglycemia associated with cardiovascular disease? The Framingham Study.
- MedicineAmerican heart journal
- 1991
Glucose tolerance and coronary heart disease: Helsinki policemen study.
- MedicineJournal of chronic diseases
- 1979
Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults.
- MedicineAmerican journal of epidemiology
- 1990
Logistic regression analyses showed these factors to be positively associated with a subsequent diagnosis of impaired glucose tolerance as well as non-insulin-dependent diabetes mellitus in women, and to a lesser degree in men, independent of baseline age and body mass index.
Asymptomatic hyperglycaemia and major ischaemic heart disease events in Britain.
- MedicineJournal of epidemiology and community health
- 1994
It is suggested that asymptomatic hyperglycaemia is an independent risk factor for major ischaemic heart disease events.
The cardiovascular risk associated with impaired glucose tolerance.
- Biology, MedicineDiabetic medicine : a journal of the British Diabetic Association
- 1996
The results suggest that there is not a continuously variable association between blood glucose levels and the risk of CVD but that the riskof CVD becomes evident at the upper end of the distribution of glucose tolerance, though different studies yield different threshold levels.
Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?
- MedicineJAMA
- 1990
Results indicate that prediabetic subjects have an atherogenic pattern of risk factors (possibly caused by obesity, hyperglycemia, and especially hyperinsulinemia), which may be present for many years and may contribute to the risk of macrovascular disease as much as the duration of clinical diabetes itself.
UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.
- MedicineDiabetologia
- 1991
The UK Prospective Diabetes Study (UKPDS) is a multi-centre, prospective, randomised, intervention trial of 5100 newly-diagnosed patients with Type 2 (non-insulin-dependent) diabetes mellitus which…
Diabetes Mellitus and Macrovascular Complications: An epidemiological perspective
- MedicineDiabetes Care
- 1992
Although the duration of NIDDM has been infrequently related to risk of CHD, the authors hypothesize that duration of hyperinsulinemia/insulin resistance would be a more sensitive marker for risk ofCHD.